Patent · US Active

Anti-TNF-alpha-antibodies and functional fragments thereof

US10759852B2 · kind B2 · utility

0Cited by

0References

17Claims

0Family size

Assignee

Numab Innovation AG · CH

Inventors

Tea Gunde · Zürich, CH
Sebastian Meyer · Bielefeld, DE

Key dates

Filing date	Mar 16, 2017
Grant date	Sep 1, 2020
Priority date	—
Expiry date	Jun 21, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/94
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to antibody molecules and functional fragments thereof, capable of binding to tumor necrosis factor alpha (TNFα), to processes for their production, and to their therapeutic uses.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.